Previous studies have shown that FNDC4 and FNDC5 in humans can inhibit adipogenesis and induce adipocyte apoptosis, thus exerting anti-obesity effects [37], indicating the close relationship between fndc4 and energy metabolism. The gene discussed is FNDC4; the disease is obesity due to melanocortin 4 receptor deficiency.